Skip to main content
. 2011 Jul;7(7):445–454.

Table 2.

Characteristics of the 16 Populations Included in the Prognostic Studies

Biomarker Disease Reference Number of patients Age (years) Male % Cirrhosis % White % Alcohol drinker % HIV % Treated %
FibroTest HCV Ngo Y, Munteanu M, Messous D, et al14 537 46 60 11 85 14 4 26
HCV Vergniol J, Foucher J, Terrebonne E, et al16 663 51 53 18 80 0 10 52
HBV Ngo Y, Benhamou Y, Thibault V, et al15 978 41 69 19 26 3 6 60
ALD Naveau S, Gaude G, Asnacios A, et al7 218 47 78 31 80 100 0 21*
APRI HCV Ngo Y, Munteanu M, Messous D, et al14 260 46 60 11 85 14 4 26
HCV Nunes D, Fleming C, Offner G, et al17 303 44 64 NA 49 25 68 NA
HCV Vergniol J, Foucher J, Terrebonne E, et al16 663 51 53 18 80 0 10 52
HBV Ngo Y, Benhamou Y, Thibault V, et al15 978 41 69 19 26 3 6 60
ALD Naveau S, Gaude G, Asnacios A, et al7 218 47 78 31 80 100 0 21*
FIB-4 HCV Nunes D, Fleming C, Offner G, et al17 303 44 64 NA 49 25 68 NA
HCV Vergniol J, Foucher J, Terrebonne E, et al16 663 51 53 18 80 0 10 52
ALD Naveau S, Gaude G, Asnacios A, et al7 218 47 78 31 80 100 0 21*
HepaScore ALD Naveau S, Gaude G, Asnacios A, et al7 218 47 78 31 80 100 0 21*
FibroMeter ALD Naveau S, Gaude G, Asnacios A, et al7 218 47 78 31 80 100 0 21*
ELF Mixed liver disease Parkes J, Roderick P, Harris S, et al18 457 42 67 17 95 10 NA NA
FibroScan HCV Vergniol J, Foucher J, Terrebonne E, et al16 663 51 53 18 80 0 10 52
*

Abstinent.

ALD

alcoholic liver disease

APRI

aspartate transaminase-platelet ratio index

HBV

hepatitis B virus

HCV

hepatitis C virus